Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Contrast Agents for Magnetic Resonance Imaging (MRI) market report explains the definition, types, applications, major countries, and major players of the Contrast Agents for Magnetic Resonance Imaging (MRI) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Spago Nanomedicine (Sweden)
Bayer HealthCare (Germany)
Daiichi Sankyo (Japan)
Lantheus (US)
JB Chemicals and Pharmaceuticals (India)
Bracco Imaging (Italy)
Guerbet (France)
Taejoon Pharm (South Korea)
GE Healthcare (US)
Jodas (India)
Unijules Life Sciences (India)
Magnus Health (India)
By Type:
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
By End-User:
Radiology
Interventional Radiology
Interventional Cardiology
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Outlook to 2028- Original Forecasts
-
2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Contrast Agents for Magnetic Resonance Imaging (MRI) Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market- Recent Developments
-
6.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Market News and Developments
-
6.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Deals Landscape
7 Contrast Agents for Magnetic Resonance Imaging (MRI) Raw Materials and Cost Structure Analysis
-
7.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Raw Materials
-
7.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Price Trend of Key Raw Materials
-
7.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Suppliers of Raw Materials
-
7.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Concentration Rate of Raw Materials
-
7.5 Contrast Agents for Magnetic Resonance Imaging (MRI) Cost Structure Analysis
-
7.5.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Raw Materials Analysis
-
7.5.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Labor Cost Analysis
-
7.5.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Expenses Analysis
8 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Import and Export Analysis (Top 10 Countries)
-
8.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Export by Region (Top 10 Countries) (2017-2028)
9 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Outlook by Types and Applications to 2022
-
9.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Barium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gadolinium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)
-
9.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Radiology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Interventional Radiology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Interventional Cardiology Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Contrast Agents for Magnetic Resonance Imaging (MRI) Market Analysis and Outlook till 2022
-
10.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.2.2 Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.2.3 Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.2 UK Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.3 Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.4 Belgium Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.5 France Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.6 Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.7 Denmark Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.8 Finland Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.9 Norway Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.10 Sweden Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.11 Poland Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.12 Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.3.13 Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.2 Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.3 India Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.4 South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.5 Pakistan Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.6 Bangladesh Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.7 Indonesia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.8 Thailand Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.9 Singapore Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.10 Malaysia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.11 Philippines Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.4.12 Vietnam Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.5.2 Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.5.3 Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.5.4 Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.5.5 Venezuela Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.5.6 Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.5.7 Puerto Rico Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.5.8 Ecuador Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.6.2 Kuwait Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.6.3 Oman Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.6.4 Qatar Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.6.5 Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.6.6 United Arab Emirates Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.7.2 South Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.7.3 Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.7.4 Algeria Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
-
10.8.2 New Zealand Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption (2017-2022)
11 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Competitive Analysis
-
11.1 Spago Nanomedicine (Sweden)
-
11.1.1 Spago Nanomedicine (Sweden) Company Details
-
11.1.2 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.1.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bayer HealthCare (Germany)
-
11.2.1 Bayer HealthCare (Germany) Company Details
-
11.2.2 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.2.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Daiichi Sankyo (Japan)
-
11.3.1 Daiichi Sankyo (Japan) Company Details
-
11.3.2 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.3.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Lantheus (US)
-
11.4.1 Lantheus (US) Company Details
-
11.4.2 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.4.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 JB Chemicals and Pharmaceuticals (India)
-
11.5.1 JB Chemicals and Pharmaceuticals (India) Company Details
-
11.5.2 JB Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 JB Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.5.4 JB Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bracco Imaging (Italy)
-
11.6.1 Bracco Imaging (Italy) Company Details
-
11.6.2 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.6.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Guerbet (France)
-
11.7.1 Guerbet (France) Company Details
-
11.7.2 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.7.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Taejoon Pharm (South Korea)
-
11.8.1 Taejoon Pharm (South Korea) Company Details
-
11.8.2 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.8.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 GE Healthcare (US)
-
11.9.1 GE Healthcare (US) Company Details
-
11.9.2 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.9.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Jodas (India)
-
11.10.1 Jodas (India) Company Details
-
11.10.2 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.10.4 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Unijules Life Sciences (India)
-
11.11.1 Unijules Life Sciences (India) Company Details
-
11.11.2 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.11.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Magnus Health (India)
-
11.12.1 Magnus Health (India) Company Details
-
11.12.2 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
11.12.4 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Outlook by Types and Applications to 2028
-
12.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Barium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Gadolinium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Radiology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Interventional Radiology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Interventional Cardiology Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Contrast Agents for Magnetic Resonance Imaging (MRI) Market Analysis and Outlook to 2028
-
13.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.2.2 Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.2.3 Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.2 UK Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.3 Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.4 Belgium Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.5 France Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.6 Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.7 Denmark Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.8 Finland Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.9 Norway Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.10 Sweden Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.11 Poland Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.12 Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.3.13 Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.2 Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.3 India Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.4 South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.8 Thailand Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.9 Singapore Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.11 Philippines Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.5.2 Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.5.3 Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.5.4 Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.5.6 Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.6.3 Oman Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.6.4 Qatar Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.7.2 South Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.7.3 Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.7.4 Algeria Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Contrast Agents for Magnetic Resonance Imaging (MRI)
-
Figure of Contrast Agents for Magnetic Resonance Imaging (MRI) Picture
-
Table Global Contrast Agents for Magnetic Resonance Imaging (MRI) Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Contrast Agents for Magnetic Resonance Imaging (MRI) Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Barium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Gadolinium-based Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)
-
Figure Global Radiology Consumption and Growth Rate (2017-2022)
-
Figure Global Interventional Radiology Consumption and Growth Rate (2017-2022)
-
Figure Global Interventional Cardiology Consumption and Growth Rate (2017-2022)
-
Figure Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Country (2017-2022)
-
Table North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Country (2017-2022)
-
Figure United States Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Table Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Country (2017-2022)
-
Figure Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure UK Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Belgium Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure France Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Denmark Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Finland Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Norway Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Sweden Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Poland Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Table APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Country (2017-2022)
-
Figure China Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure India Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Thailand Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Singapore Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Philippines Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Table South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Country (2017-2022)
-
Figure Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Table GCC Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Country (2017-2022)
-
Figure Bahrain Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Oman Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Qatar Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Table Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Country (2017-2022)
-
Figure Nigeria Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure South Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure Algeria Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Table Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption by Country (2017-2022)
-
Figure Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption and Growth Rate (2017-2022)
-
Table Spago Nanomedicine (Sweden) Company Details
-
Table Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table Bayer HealthCare (Germany) Company Details
-
Table Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table Daiichi Sankyo (Japan) Company Details
-
Table Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table Lantheus (US) Company Details
-
Table Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table JB Chemicals and Pharmaceuticals (India) Company Details
-
Table JB Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table JB Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table JB Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table Bracco Imaging (Italy) Company Details
-
Table Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table Guerbet (France) Company Details
-
Table Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table Taejoon Pharm (South Korea) Company Details
-
Table Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table GE Healthcare (US) Company Details
-
Table GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table Jodas (India) Company Details
-
Table Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table Unijules Life Sciences (India) Company Details
-
Table Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Table Magnus Health (India) Company Details
-
Table Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Main Business and Markets Served
-
Table Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolio
-
Figure Global Barium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gadolinium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interventional Radiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interventional Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast by Country (2022-2028)
-
Table North America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast by Country (2022-2028)
-
Figure United States Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast by Country (2022-2028)
-
Figure Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast by Country (2022-2028)
-
Figure China Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast by Country (2022-2028)
-
Figure Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast by Country (2022-2028)
-
Figure Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Contrast Agents for Magnetic Resonance Imaging (MRI) Consumption Forecast and Growth Rate (2022-2028)
-
